Clinical Trials Browser

Breast Cancer Lymphedema

NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Phase NA Active not recruiting

72 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01992952 2025-11-26

FAKTION

Phase 1/2 Active not recruiting

149 enrolled

Breast

Estrogen Receptor Positive Breast Cancer

NCT06522971 2025-09-10

CancerBeat

Phase NA Active not recruiting

55 enrolled

Breast

Breast Neoplasms

NCT03578484 2025-07-04

Breast Aesthetics by Three Dimensional Measures

Active not recruiting

32 enrolled

Breast

Breast Neoplasms

NCT03963427 2025-07-03

GoBreast

Phase NA Active not recruiting

220 enrolled

Breast

Breast Cancer Female

NCT04461808 2025-06-25

MAITA

Phase NA Active not recruiting

10,156 enrolled

Breast

Breast Neoplasms

NCT04862429 2025-06-25

BoCCE

Phase NA Active not recruiting

200 enrolled

Breast

Breast Neoplasms, Calcinosis

NCT06394661 2025-06-23

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Phase 2 Active not recruiting

109 enrolled

Breast

Breast Neoplasms

NCT05309265 2025-06-13

VocRehab

Phase NA Active not recruiting

16 enrolled

Breast

Breast Neoplasms

NCT05969314 2025-04-11

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Phase 1 Active not recruiting

12 enrolled

BreastHead & Neck

Breast Neoplasms, Mouth Neoplasms

NCT01916317 2025-04-09

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Phase 3 Active not recruiting

1,600 enrolled

Breast

Operable Breast Cancer

NCT02161900 2025-04-09

Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer

Phase NA Active not recruiting

850 enrolled

Breast

Non Metastatic Operable Breast Cancer

NCT03168880 2025-04-09

TNBC

Phase 3 Active not recruiting

720 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05682885 2025-01-22

ELYBS

Phase NA Active not recruiting

140 enrolled

Breast

Breast Cancer Lymphedema

NCT03408717 2024-10-09

B-CAPP

Active not recruiting

220 enrolled

Breast

Anxiety Disorders, Breast Neoplasms, Depression, Chronic Pain, Acute Pain

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Phase 2 Active not recruiting

200 enrolled

Breast

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT03756298 2023-11-09

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 2 Active not recruiting

284 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

BCRL

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

FAKTION

CancerBeat

Breast Aesthetics by Three Dimensional Measures

GoBreast

MAITA

BoCCE

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

VocRehab

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer

TNBC

ELYBS

B-CAPP

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer